# Aurora Cannabis Inc: financial statements, quarterly

ACB · Nasdaq · CIK 1683541 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/acb.md) · [Financials](/companies/acb/financials.md) · [Filings](/companies/acb/filings.md) · [Insiders](/companies/acb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/acb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2022 (2022-06-30) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | Q4 FY2025 (2025-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Gross profit | $m | not reported | [42.9](/filings/0001683541-25-000008.md) | [42.2 d](/filings/0001683541-25-000008.md) | [74.9 d](/filings/0001683541-25-000008.md) | [27.6 d](/filings/0001683541-25-000008.md) |
| Operating income | $m | not reported | [(1.0)](/filings/0001683541-25-000008.md) | [(2.6) d](/filings/0001683541-25-000008.md) | [32.6 d](/filings/0001683541-25-000008.md) | [(24.0) d](/filings/0001683541-25-000008.md) |
| Net income | $m | [0.0 d](/filings/0001683541-22-000002.md) | [3.8](/filings/0001683541-25-000008.md) | [(13.2) d](/filings/0001683541-25-000008.md) | [28.2 d](/filings/0001683541-25-000008.md) | [(17.2) d](/filings/0001683541-25-000008.md) |
| Diluted EPS | $ per share | not reported | [0.10](/filings/0001683541-25-000008.md) | not reported | not reported | not reported |
| Basic EPS | $ per share | not reported | [0.10](/filings/0001683541-25-000008.md) | not reported | not reported | not reported |

- Gross profit: ifrs-full:GrossProfit
- Operating income: ifrs-full:ProfitLossFromOperatingActivities
- Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent, ifrs-full:ProfitLoss
- Diluted EPS: ifrs-full:DilutedEarningsLossPerShare
- Basic EPS: ifrs-full:BasicEarningsLossPerShare

## Balance sheet

| Line item | Unit | period not labelled (2017-06-30) | period not labelled (2018-06-30) | FY2019 (2019-06-30) | FY2020 (2020-06-30) | FY2021 (2021-06-30) | FY2022 (2022-06-30) | FY2024 (2023-03-31) | FY2024 (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | period not labelled (2024-12-31) | FY2025 (2025-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [160](/filings/0001683541-19-000008.md) | [76.8](/filings/0001628280-20-013898.md) | [173](/filings/0001683541-21-000003.md) | [162](/filings/0001683541-22-000002.md) | [421](/filings/0001683541-23-000007.md) | [438](/filings/0001683541-24-000009.md) | [256](/filings/0001683541-25-000008.md) | [136](/filings/0001683541-25-000008.md) | [138](/filings/0001683541-25-000008.md) | [108](/filings/0001683541-25-000008.md) | [133](/filings/0001683541-25-000008.md) | [138](/filings/0001683541-25-000008.md) |
| Current assets | $m | not reported | [220](/filings/0001683541-19-000008.md) | [661](/filings/0001628280-20-013898.md) | [418](/filings/0001683541-21-000003.md) | [666](/filings/0001683541-22-000002.md) | [745](/filings/0001683541-23-000007.md) | [480](/filings/0001683541-24-000009.md) | [427](/filings/0001683541-25-000008.md) | [438](/filings/0001683541-25-000008.md) | [416](/filings/0001683541-25-000008.md) | [489](/filings/0001683541-25-000008.md) | [478](/filings/0001683541-25-000008.md) |
| Total assets | $m | not reported | [1,887](/filings/0001683541-19-000008.md) | [5,499](/filings/0001628280-20-013898.md) | [2,780](/filings/0001683541-21-000003.md) | [2,605](/filings/0001683541-22-000002.md) | [1,084](/filings/0001683541-23-000007.md) | [926](/filings/0001683541-24-000009.md) | [839](/filings/0001683541-25-000008.md) | [837](/filings/0001683541-25-000008.md) | [807](/filings/0001683541-25-000008.md) | [862](/filings/0001683541-25-000008.md) | [853](/filings/0001683541-25-000008.md) |
| Current liabilities | $m | not reported | [75.2](/filings/0001683541-19-000008.md) | [436](/filings/0001628280-20-013898.md) | [272](/filings/0001683541-21-000003.md) | [116](/filings/0001683541-22-000002.md) | [131](/filings/0001683541-23-000007.md) | [238](/filings/0001683541-24-000009.md) | [125](/filings/0001683541-25-000008.md) | not reported | not reported | not reported | [111](/filings/0001683541-25-000008.md) |
| Total liabilities | $m | not reported | [334](/filings/0001683541-19-000008.md) | [1,112](/filings/0001628280-20-013898.md) | [657](/filings/0001683541-21-000003.md) | [567](/filings/0001683541-22-000002.md) | [422](/filings/0001683541-23-000007.md) | [405](/filings/0001683541-24-000009.md) | [237](/filings/0001683541-25-000008.md) | not reported | not reported | not reported | [244](/filings/0001683541-25-000008.md) |
| Shareholders' equity | $m | [219](/filings/0001683541-19-000008.md) | [1,548](/filings/0001683541-19-000008.md) | [4,383](/filings/0001628280-20-013898.md) | [2,148](/filings/0001683541-21-000003.md) | [2,038](/filings/0001683541-22-000002.md) | [662](/filings/0001683541-23-000007.md) | [491](/filings/0001683541-24-000009.md) | [560](/filings/0001683541-25-000008.md) | not reported | not reported | not reported | [567](/filings/0001683541-25-000008.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 56,234,231 at 2025-03-31, from the cover of the [40-F filed 2025-06-18](/filings/0001683541-25-000008.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.